RNU6-358P

Across TCGA pan-cancer cohorts, RNU6-358P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU6-358P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-358P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-358P expression acts as an unfavorable survival marker, although some lineages such as LUSC and LAML show a favorable association.

KIRC, UVM, and UCS are the cancer types where RNU6-358P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Quartile	All	0.514	0.662	<.001	174	view →
UVM	DFS	Tertile	All	0.261	0.771	.005	81	view →
UCS	DFS	Tertile	IV	0.237	0.840	<.001	54	view →
ACC	OS	Tertile	All	0.446	0.810	.005	54	view →
READ	DFS	Tertile	All	0.255	0.844	.004	45	view →
PAAD	OS	Tertile	II,III,IV	0.326	0.600	.003	39	view →
STAD	OS	Tertile	II,III,IV	0.346	0.606	.015	36	view →
LUSC	DFS	Tertile	II,III,IV	1.000	0.569	.015	36	view →
THYM	DFS	Tertile	All	0.226	0.763	.002	15	view →
CHOL	DFS	Tertile	All	0.037	0.497	.004	9	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	9	view →
LIHC	DFS	Tertile	III,IV	0.094	0.424	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU6-358P–KIRC (DFS)

Open the KIRC breakdown →